Kole Roybal

"Kole Roybal"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hyrenius-Wittsten A, Su Y, Park M, et al. (2021) SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models. Science Translational Medicine. 13
Choe JH, Watchmaker PB, Simic MS, et al. (2021) SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma. Science Translational Medicine. 13
Huang X, Williams JZ, Chang R, et al. (2020) DNA scaffolds enable efficient and tunable functionalization of biomaterials for immune cell modulation. Nature Nanotechnology
Williams JZ, Allen GM, Shah D, et al. (2020) Precise T cell recognition programs designed by transcriptionally linking multiple receptors. Science (New York, N.Y.). 370: 1099-1104
Ramkumar P, Abarientos AB, Tian R, et al. (2020) CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma. Blood Advances. 4: 2899-2911
Landgraf KE, Williams SR, Steiger D, et al. (2020) convertibleCARs: A chimeric antigen receptor system for flexible control of activity and antigen targeting. Communications Biology. 3: 296
Roth TL, Li PJ, Blaeschke F, et al. (2020) Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies. Cell
Hyrenius-Wittsten A, Roybal KT. (2019) Paving New Roads for CARs. Trends in Cancer. 5: 583-592
Azimi CS, Tang Q, Roybal KT, et al. (2019) NextGen cell-based immunotherapies in cancer and other immune disorders. Current Opinion in Immunology. 59: 79-87
Pai CS, Huang JT, Lu X, et al. (2019) Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade. Immunity
See more...